Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
83 results about "Griseofulvin" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
This medication is used to treat fungal infections of the skin, hair, and nails that do not respond to creams/lotions.
Methods of making and using novel griseofulvin compositions
Owner:ELAN PHRMA INT LTD
Method of treatment of otitis externa
This invention relates to a method of treating otitis externa, and in particular otitis externa of fungal etiology, using topical medication, including antifungal agents such as, for example fluconazole, voriconazole, itraconazole, clotrimazole, amphotericin B, caspofungin (Cancidas®), micafungin (Mycamine®), terbinafine, naftifine, butenafine, amorolfine, ravuconazole, posaconazole, flucytosine, econazole, enilaconazole, miconazole, oxiconazole, saperconazole, sulconazole, terconazole, tioconazole, nikkomycin Z, anidulafungin (LY303366), nystatin, pimaricin, griseofulvin, ciclopirox, haloprogin, tolnaftate, and undecylenate.
Owner:FAIRFIELD CLINICAL TRIALS
Method for removing griseofulvin in biological medicine waste residues
ActiveCN106110562AHigh removal rateIncrease production capacityChemical protectionSlurrySolid content
The invention relates to a method for removing griseofulvin in biological medicine waste residues. The method for removing the griseofulvin in the biological medicine waste residues specifically comprises the following steps of (1) a pretreatment process including the sub-steps that (1-1) the to-be-treated biological medicine waste residues containing the griseofulvin is mixed with water, and waste residue slurry with the solid content being 5%-45% is prepared through slurry mixing and dispersing, and (1-2) the waste residue slurry is sterilized; and (2) a catalytic and oxidative degradation process, specifically, catalytic and oxidative degradation is conducted by adding an oxidative and catalytic agent into the sterilized waste residue slurry, and then filtering separation and drying are conducted. Compared with the prior art, a wet catalytic and oxidative treatment integrated technique is used for removing the griseofulvin left in the waste residues, the removal rate is high, secondary pollutants are avoided, and harmless treatment is achieved; the concentration of the griseofulvin left in the waste residues can be rapidly decreased to 0-50 ppm from the original 1000-5000 ppm, the mass reduction rate of the biological medicine waste residues is smaller than 10%, and the method has extremely good application prospects.
Owner:SHANGHAI RES INST OF CHEM IND
Exterior-applied medicine for treating dermatopathy
InactiveCN101129522ANot corrosiveSignificant effectHydroxy compound active ingredientsDermatological disorderDiseaseDexamethasone acetate
The invention discloses an externally-used medicament for treating skin diseases, which is prepared from Chinese honey locust, Clematis chinensis, hooked uncaria, arisaema tuber, cnidium fruit, boneol, camphor, menthol, dried alum, broom cypress fruit, cactus, sea tangle, vitamin C, ciprofloxacin hydrochloride, vitamins, griseofulvin, abomacetin enteric coated tablet, dexamethasone acetate tablet, compound sulfalene oxazole tablet, sesame oil, edible glycerol, seed powder of Gorgon euryale and 20 Degree light wine.
Owner:滕大浪
Culture medium for producing griseofulvin by fermentation
The invention discloses a culture medium for producing fermentation by fermentation, which comprises a seed culture medium and a fermentation medium. In the process of fermentation culture, when total sugar reduces to 2.0-3.0%, a feed supplement culture medium is added; and corn is used as a main carbon source to prepare the fermentation culture medium. Preferentially, the seed culture medium and the feed supplement culture medium are also prepared by using the corn as the main carbon source. Since the price of corn flour is much lower than that of rice flour, the production cost is greatly reduced; in addition, the corn flour has sufficient supply and stable quality, thereby ensuring the stability of fermentation production.
Owner:CHIFENG PHARMA CO LTD
Chinese and western medicinal composition for treating empyrosis
ActiveCN101850000ARapid epithelial repairPain relieverHydroxy compound active ingredientsTetracycline active ingredientsEpitheliumRepair tissue
Owner:张十方
Preparation method of avermectin-griseofulvin composite nano-emulsion pesticide
ActiveCN103461360ANo pesticide residueStrong medicineBiocideAnimal repellantsNicotiana tabacumOil phase
The invention discloses a preparation method of an avermectin-griseofulvin composite nano-emulsion pesticide. The avermectin-griseofulvin composite nano-emulsion pesticide is prepared from 10 parts of avermectin, 5-15 parts of griseofulvin, 100-200 parts of an oil phase, 20-40 parts of an emulsifier and 10-15 parts of a co-emulsifier. Compared with the prior art, the avermectin-griseofulvin composite nano-emulsion pesticide has the characteristics of good medicinal stability, strong medicinal effects and long action period. The avermectin-griseofulvin composite nano-emulsion pesticide has stomach poisoning and contact toxicity effects on mites and insects, is mainly used for killing internal and external parasites of livestock and poultry and injurious insects of crops, and can prevent and control a plurality of injurious insects such as parasitic red insects, dipteran, coleopteran, lepidopteran and pest mites on a plurality of crops such as orange, woods, cotton, vegetables, tobacco and paddy rice.
Owner:江苏物网慧农科技集团有限公司
Preparation method of griseofulvin
The invention discloses a preparation method of griseofulvin. The preparation method comprises the following steps of: A, heating griseofulvin fermentation liquor, adding calcium oxide to adjust the PH, carrying out solid-liquid separation by using a sheet frame, adding calcium oxide to a filter cake to granulate, and extracting by using acetone to obtain a griseofulvin acetone extracting solution; B, decoloring the griseofulvin acetone extracting solution by using an active carbon column to obtain a griseofulvin decoloring solution, feeding the decoloring solution into a concentration tank, and crystallizing by concentrating to obtain wet griseofulvin crystals; and C, washing the wet griseofulvin crystals once by using a dichloromethane and ethanol mixed solution while stirring, then washing the wet griseofulvin crystals once by using medicinal ethanol with the concentration of 95 percent while stirring, drying the crystals by using a vacuum drier, and carrying out superfine grinding on the dried crystals to obtain the griseofulvin product. Compared with a traditional preparation method, the preparation method disclosed by the invention has the advantages that the crystallization times in the process of preparing the griseofulvin in the prior art is reduced, the yield loss caused by recrystalization of griseofulvin is effectively avoided, the total yield of the griseofulvin is improved by 7-10 percent, and the production cost is greatly reduced.
Owner:内蒙古格林特制药有限责任公司
Compound external remedy for treating psoriasis
InactiveCN1600300AGood curative effectSmall toxicitySalicyclic acid active ingredientsAntimycoticsAntifungalRegimen
An externally-applied compound medicine in the form of ointment, cream, lotion, liniment or aerosol for treating skin tinea is prepared from butenafine hydrochloride, other antifungal medicines (salicylic acid, spirofulvin, amorolfine, etc), and assistant.
Owner:李跃亨
Culture medium for producing griseofulvin through fermentation of penicillium expansum and culture method
InactiveCN106480121AGood fermentation processGood control parametersFungiMicroorganism based processesBiotechnologyNitrogen source
The invention relates to a culture medium for producing griseofulvin through fermentation of penicillium expansum and a culture method. A seed culture medium for producing griseofulvin through fermentation of penicillium expansum, a carbon source and a nitrogen source in a fermentation culture medium and the best compatibility proportion are confirmed. With the adoption of the formula of the culture medium and the fermentation control process, the fermentation unit of griseofulvin can be increased, the fermentation cost can be reduced, raw materials and auxiliary materials are reduced to the largest extent, are free of environmental influence and can be sufficiently supplied, and stable and efficient production of griseofulvin is realized.
Owner:宁夏泰瑞制药股份有限公司
Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease
InactiveCN1526406AHigh inclusion rateConstant releasePowder deliveryOrganic active ingredientsDiseaseAbamectin
The present invention is the preparation process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease. The obviously raised inclusion rate of the medicine in beta-cyclodextrin makes the new medicine preparation form efficient and stable in preventing and treating animal's dermatosis. The technological scheme is that griseofulvin, abamectin or ivermectin and beta-cyclodextrin in reasonable proportion as main materials are prepared into the combined delayed releasing agent powder or injection via certain technological process including mixing, drying, crushing, packing and other steps. The said medicine is used mainly in preventing and treating tinea pedis and mite disease of rabbit, pig, sheep, dog, cat, ox and other animals.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
Strain for producing Songgang mycin main component griseofulvin as well as method
The invention discloses a strain for producing a Songgang mycin main component griseofulvin as well as a method. The invention provides penicillium griseofulvum FA868, and the preservation number in the China Center for Typical Culture Collection (CCTCC) is CCTCC NO:M 2018186. The Songgang mycin main component griseofulvin is produced by using the penicillium griseofulvum FA868; the whole processof biologically synthesizing the griseofulvin can be completed without taking lactose and core pulp as main raw materials and through simple seeds and fermentation formula of taking rice as carbon andnitrogen sources and adding a proper amount of inorganic salt; and the characteristics of a high-resistance precursor-chloride is maintained, the total amount of the chloride can reach to above 2.0 percent in the fermentation process, and the dechlorinated griseofulvin content is guaranteed to be below 0.2 percent. A reliable raw material source is provided for developing Songgang mycin serving as anti-fungal biological pesticide.
Owner:福州工微生物科技有限公司
Skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation and using method thereof to beriberi skin disease
InactiveCN101810720AAvoid painAvoid rebound situationsAntibacterial agentsPowder deliveryDiseaseSweat gland
The invention discloses a skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation, which comprises the following raw materials in part by weight: 10 to 100 parts of talcpowder, 1 to 20 parts of metronidazole, 1 to 10 parts of phellodendron, 1 to 10 parts of borneol, 1 to 10 parts of menthol, 1 to 10 parts of griseofulvin, 1 to 5 parts of chloramphenicol, 1 to 5 parts of sulfamethoxazole, 1 to 5 parts of aspirin, 1 to 5 parts of alum, 1 to 3 parts of chlortrimeton and 1 to 3 parts of vitamin B1. The invention also relates to a using method of the skin disease external powder for comprehensively killing and inhibiting bacteria and diminishing inflammation to beriberi skin disease. The medicaments are effectively combined, and the effects of the medicaments are supported one another, so the skin disease external powder has the effects of comprehensively killing poison, killing and inhibiting bacteria, diminishing inflammation, relieving itching, killing pain, clearing away heat, releasing toxin, restraining sweat gland, removing sweat and deodorizing on an affected part, and simultaneously has effects of killing and inhibiting bacteria and disinfecting on the environment of the affected part so as to fulfill the aims of radically curing fungi and bacterial infection skin disease and restoring the skin.
Owner:徐金刚
Topical antifungal treatment
The present invention is a topical skin preparation for treatment of fungal infections of the skin and nails. The preparation comprises triacetin in combination with one or more antifungal agents. In a preferred form, the preparation comprises a combination of the antifungal agents tolnaftate and grisiofulvin are used in combination with triacetin. The concentrations of these constituents are 40 to 50% concentration triacetin, 30 to 50% acetone, 0.5-3.0% concentration tolnaftate and 0.5-4.0% concentration grisiofulvin, in one preferred embodiment. Other compounds, such as ethyl alcohol, acetone, amino acids such as n-acetylcysteine, and herbal additives may also be added to the preparation. Further, other antifungal agents such as nystatin, clortimazole, econazole, ketoconazole, miconazole, solconazole, oxiconizole, naftifine, terbinafine, and butenafine, for example, may be substituted for the antifungal agents tolnaftate and grisiofulvin. The preparation of the present invention is effective in treating immune compromised patients and those with diabetes, as well as relatively healthy persons.
Owner:BOMMARITO ALEXANDER A
Method for producing penicillium griseofulvum, main ingredient of Songgang mycin, through microbial fermentation
ActiveCN108841889AImprove fermentation titerReduce manufacturing costMicroorganism based processesFermentationBiotechnologyMicroorganism
The invention discloses a method for producing penicillium griseofulvum, a main ingredient of Songgang mycin, through microbial fermentation. The method comprises the following steps: fermenting and culturing penicillium griseofulvum FH1816, to obtain penicillium griseofulvum from a fermented product, wherein the preservation number of the penicillium griseofulvum FH1816 in the China Center for Type Culture Collection is CCTCC NO:M 2018187. The provided penicillium griseofulvum FH1816 is used to produce the penicillium griseofulvum, a material route using no lactose or corn syrup and the novelprocess of feeding in batches, supplementing chlorine and fermenting are adopted, the fermentation potency of the penicillium griseofulvum is greatly improved, the production cost is lowered, and themethod provides reliable material sources for developing the antifungal biopesticide, namely the Songgang mycin.
Owner:福州工微生物科技有限公司
Medicine combination preparation as well as preparation method and application thereof
InactiveCN104069326ASimple manufacturing methodGood treatment effectHeavy metal active ingredientsHydroxy compound active ingredientsDexamethasone acetateCinnabar
The invention relates to the field of external-use medicine and in particular relates to a medicine combination preparation as well as a preparation method and application thereof. The medicine combination preparation comprises the following components: sanguisorba officinalis, gypsum fibrosum, rheum officinale, hazel flower, cortex phellodendri, resina draconis, cinnabar, borneol, radix notoginseng powder, compound sulfamethoxazole tablets, griseofulvin tablets, dexamethasone acetate tablets, furazolidone tablets, camphor, vitamin B2, vitamin C tablets, cyproheptadine hydrochloride tablets and nitrofurantoin tablets. The medicine combination preparation has the functions of killing parasites to relieve itching, diminishing swelling and removing stasis, eliminating putridity and removing pus, drawing out pus and toxin, removing putridity and pterygium, engendering flesh and closing wounds, astringing to stop bleeding, dispelling wind and removing obstruction in the meridians, making diarrhea and removing food stagnation, dissipating stasis and stabilizing pain, breaking swelling and removing symptom and the like, so that the medicine combination preparation is good in effect of treating scalds and burns, haemorrhoids, sores and wounds. The preparation method of the medicine combination preparation is simple and easy to operate; the prepared medicine combination preparation is remarkable in treatment effect.
Owner:杨华
Griseofulvin-producing strain and application thereof
ActiveCN108823110AImprove fermentation titerReduce manufacturing costBiocideFungiAntifungalBiotechnology
The invention discloses a griseofulvin-producing strain and application thereof. The invention provides Penicillium griseofulvum FH1816, which has a preservation number of CCTCC NO: M 2018187 in ChinaCenter for Type Culture Collection. The Penicillium griseofulvum FH1816 provided by the invention is utilized to produce griseofulvin, a raw material route without using lactose and corn syrup and anew process of fed-batch fermentation with continuous feeding of chlorine are adopted, the fermentation potency of griseofulvin can be greatly increased, and the production cost can be reduced, and areliable raw material source is provided for development of the antifungal biopesticide songgangmeisu.
Owner:福州工微生物科技有限公司
Gel ointment for treating tinea capitis
InactiveCN1927199AGood treatment effectNo side effectsOrganic active ingredientsAntimycoticsMedicineD ointment
Disclosed is a gel ointment for the treatment of tinea capitis, wherein the main constituents include griseofulvins, glycerin, glyceryl stearate, Tween-20, Vaseline, methyl hydroxybenzoate, gelling agent Sa and distilled water.
Owner:TIANJIN WEALTH BIOENGINEERING SCI & TECH CO LTD
Griseofulvin compound
ActiveUS10570109B2Preventing and/or treating an inflammatory diseaseAdvantageously producedOrganic active ingredientsOrganic chemistryPharmacometricsOrganic chemistry
An object of the present invention is to provide a compound having an anti-inflammatory activity or a pharmacologically acceptable salt thereof.The solution of the present invention is a compound of general formula (1) or a pharmacologically acceptable salt thereof.wherein the symbols in the formula are defined below: R1: e.g., a C1-C6 alkyl group; R2: a C1-C6 alkyl group; A: e.g., an oxygen atom; and R3: e.g., a C1-C6 alkyl group.
Owner:DAIICHI SANKYO CO LTD
Water glass anti-staling agent for eggs
The invention discloses a water glass anti-staling agent for eggs. The water glass anti-staling agent comprises water glass, vitamin C, griseofulvin and water. The water glass anti-staling agent of the invention has the advantages of reasonable formula, good usage effect and low production cost.
Owner:王海东
Separation preparation method for human primary cancer cells
InactiveCN107254446AIncrease concentrationPromote rapid proliferationCell dissociation methodsCulture processPlant SourcesY-27632
The invention provides a separation preparation method for human primary cancer cells. According to the separation preparation method, the culture process is divided into two periods, culture is carried out with culture mediums with fetal calf serum of different concentrations respectively, the concentrations of the fetal calf serum in the culture mediums are increased gradually, then the adaptability and the activity of primary cancer cells are improved gradually, relatively rapid cell proliferation and relatively high yield are achieved, and meanwhile good hereditary stability is achieved; due to addition of sodium pyruvate, MaxCitro, Y-27632 and griseofulvin, bacterial and fungal infection can be prevented, cell proliferation can be promoted, and cell differentiation can be inhibited; and due to addition of a plant source recombinant human serum albumin in a cryoprotectant, a part of fetal calf serum can be replaced, the use amount of the fetal calf serum can be reduced, and thus the cost can be lowered on premise that the effect is not affected.
Owner:CENTURY BIOSTRENGTH BEIJING PTY LTD
Griseofulvin production strain culture medium
The invention discloses a griseofulvin production strain culture medium. The griseofulvin production strain medium is prepared from the following raw materials in parts by weight: 700-900 parts of water, 35-70 parts of corn flour, 3-4 parts of potassium dihydrogen phosphate, 1-2 parts of sodium chloride, 1-1.5 parts of potassium chloride, 1-1.5 parts of ammonium sulfate, 1-2 parts of sodium nitrate, 1-2 parts of ferrous sulfate and 3-5 parts of calcium carbonate. By using the griseofulvin production strain culture medium for producing a griseofulvin production strain, the quality is stable, the reproductivity is high, the cost is low, and economic benefits are significant.
Owner:CHIFENG PHARMA CO LTD
Medicine for treating burns and scalds, acne rosacea and acnes and preparation method thereof
InactiveCN104367906AEffective treatmentPromote growth recoveryAnthropod material medical ingredientsHydroxy compound active ingredientsAngelica Sinensis RootVitamin K3
The invention discloses a medicine for treating burns and scalds, acne rosacea and acnes. The medicine is prepared from the following raw materials: radix stemonae, Chinese blister beetle, semen arecae, bletilla striata, rhizoma arisaematis, cortex pseudolaricis, radix angelicae, rhubarb root, asarum, nux vomica, realgar, alumen, borneol, gleditsia sinensis lam, plantain herb, cortex dictamni, monkshood, radix aconiti agrestis, oldenlandia diffusa, sulphur, camphor, mint, angelica sinensis, schisandra chinensis, honeysuckle, flowers carthami, frankincense, coptis chinensis, myrrh, musk, gentamicin, erythrocin, tetracycline, chloromycetin, dexamethasone, oxytetracycline, nysfungin, griseofulvin, vitamin B1, vitamin B2, vitamin C, vitamin B6, hemostatic acid, sulfanilamide, vitamin K3, salicylic acid ester and a sulfanilamide ointment. The medicine disclosed by the invention is capable of treating burns and scalds, and has the characteristics of good curative effect and small side effect.
Owner:晏洪友
Nano-emulsion insecticide and preparation method thereof
The invention provides a nano-emulsion insecticide including: 1-2 parts of cyhalothrin, 0.1-0.6 parts of spinosad, 0.2-0.9 parts of sophocarpidine, 11-21 parts of a nano titanium dioxide, 200-310 parts of soya bean oil, 52-71 parts of yolk lecithin, 11-17 parts of n-butyl alcohol, 0.2-0.6 parts of Tween, 10-11 parts of abamectin and 5-15 parts of griseofulvin. Compared with the prior art, the nano-emulsion insecticide is low in cost and simple in processes, has excellent insecticidal effect even under very low dosage, has long lasting time and has low damage on ecological system.
Owner:GUANGXI UNIV
Griseofulvin strain solid medium
InactiveCN110669678AEasy to prepareImprove work efficiencyFungiMicroorganism based processesBiotechnologySporeling
The invention discloses a griseofulvin strain solid medium. The griseofulvin strain solid medium is prepared from the following raw materials in parts by weight: 100-150 parts of potato starch, 20-30parts of sucrose, 2-4 parts of monopotassium phosphate, 3-4 parts of potassium chloride, 1-2 parts of sodium nitrate, 0.4-0.5 part of magnesium sulfate, 0.01-0.02 part of ferrous sulfate and 15-25 parts of agar. The medium is smooth in surface, moderate in hardness and uniform in inoculation; strains cultured by the medium are full in bacterial colony, white in color, round in shape, large in spore quantity, good in spore synchronization and stable in strain fermentation unit; and the medium is convenient to prepare, simple and easy to learn and high in work efficiency.
Owner:CHIFENG PHARMA CO LTD
Preparation method of griseofulvin microcrystals
ActiveCN106831678AEasy to produceSimple processAntimycoticsOrganic chemistry methodsBioavailabilitySURFACTANT BLEND
The invention relates to the field of medicines and provides a preparation method of griseofulvin microcrystals, aiming at solving the problem that the grain diameter of griseofulvin microcrystals prepared by a conventional method is relatively large. The preparation method comprises the following steps: firstly, preparing a griseofulvin organic solution, and a water solution of a surfactant and thickener mixture; secondly, adding the griseofulvin organic solution into the water solution of the surfactant and thickener mixture; and after mixing, filtering and drying to obtain the griseofulvin microcrystals. According to the preparation method, the grain diameter of the griseofulvin microcrystals prepared by the preparation method is less than 1 micron; and meanwhile, a production flow is simple, the operation is convenient and the bioavailability of a product is high, so that the preparation method is suitable for industrialized large-scale production.
Owner:ZHEJIANG FORESTRY UNIVERSITY
Ointment for treating beriberi and its preparing method
InactiveCN1480169AGood analgesic effectEffective sterilization and antibacterialAntimycoticsAnthropod material medical ingredientsBeriberiPropolis
An ointment for treating beriberi is prepared through pulverizing propolis by 40-60 meshes, immersing it along with flavescent sophora root, ciccada slough and shrubalthea bark in alcohol, sealing for 7 days while stirring once each day, filtering, mixing with royal jelly, mint oil and griseofulvin, and sealing for 3 days. Its advantages are radically treating and no recurrence.
Owner:杜玉贵
Method for performing induced mutation on griseofulvin strain through diethyl sulfate and ultraviolet rays
InactiveCN109055350AOvercome the defects that the strains are not good enoughOvercome the defects that are not good enoughMutant preparationElectrical/wave energy microorganism treatmentGlass ballUltraviolet
The invention discloses a method for performing induced mutation on griseofulvin strain through diethyl sulfate and ultraviolet rays. The method comprises the following steps: firstly, crushing selected bacterial colony through glass balls, preparing spore suspension, sucking 1ml of single spore suspension, diluting to obtain a contrast, and adding filtrate to double discs in which a diethyl sulfate containing culture medium is prepared in advance; uniformly irradiating for 30mn through the ultraviolet rays, covering with a black cloth, diluting with sterile water, uniformly applying onto a flat vessel to obtain a single bacterial colony, transferring the single bacterial colony into a constant-temperature box for culturing, selecting a mitogenetic single bacterial colony 8 days after thebacterial colony grows, and transferring the mitogenetic single bacterial colony into a bevel for culturing for 8 days; transferring the manure bacterial colony into a shake flask for primarily screening, selecting 10 bevels of which the potency unit is 3% more than the beginning bacterial colony, transferring the bevel, culturing until the bacterial colony is manure, and screening again through the shake flask; selecting 5 bevels with relatively high unit after screening again, burying the bevels with corresponding numbers into sandy soil, and storing. With the adoption of the method, the fermenting unit can be further increased; and the strain can remain outstanding properties.
Owner:内蒙古格林特制药有限责任公司
Medicine for treating beri-beri
InactiveCN1562078AShort course of treatmentQuick resultsAntimycoticsInorganic active ingredientsDiphenhydramineRealgar
Owner:李文章
Medicament for external use for treating onychomycosis
InactiveCN101564426AImprove permeabilityShort treatment timeAntimycoticsHydroxy compound active ingredientsTherapeutic effectSemen
The invention discloses a medicament for external use for treating onychomycosis. Raw material components are dried, the material mixing is performed according to the mixture ratio, the raw material components are evenly mixed and ground, and the powder is sieved and blended into paste by a moistening blender to obtain a finished product. The raw material components comprise the following materials by weight portion: 3 to 5 portions of nux vomica, 1 to 3 portions of alum, 2 to 3 portions of borneol, 2 to 3 portions of glossy ganoderma powder, 2 to 3 portions of griseofulvin tablets, 1 to 3 portions of sulfur, and 1 to 3 portions of semen aesculi. The moistening blender is lactic acid. The medicament has the advantages of short treatment time, no pain during the treatment, convenient treatment, high therapeutic effect, few pharmaceutical components and the like. The medicament can treat and eradicate refractory thymion caused by viruses such as verrucae, voix pedis and the like.
Owner:徐光丽
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com